Venous Thromboembolism (VTE) Clinical Trial
Official title:
Evaluation of Hospital Healthcare Utilization and Costs Among Hospitalized Venous Thromboembolism (VTE) Patients Treated With Apixaban or Warfarin in the United States
A study involving real-world database analysis to evaluate the hospital healthcare utilization and costs, and all-cause, major bleeding-, clinically relevant bleeding-, any bleeding-, and venous thromboembolism (VTE)-related hospital readmissions among hospitalized VTE patients treated with apixaban or warfarin, with or without low molecular weight heparin (LMWH)
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03265054 -
Evaluation of the Predictive Value of the Microvesicle Coagulo-lytic Balance in the Recurrence of Venous Thrombosis
|
N/A | |
Completed |
NCT01119274 -
EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon
|
Phase 4 | |
Completed |
NCT03965741 -
Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners
|
||
Completed |
NCT02798471 -
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
|
Phase 3 | |
Completed |
NCT01583218 -
Acute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)
|
Phase 3 | |
Completed |
NCT03521908 -
A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot
|
||
Recruiting |
NCT03802929 -
Diagnostic and Prognostic Prediction Models for Chinese Patients With Venous Thromboembolism
|
||
Completed |
NCT02073682 -
Cancer Venous Thromboembolism (VTE)
|
Phase 3 | |
Completed |
NCT03977870 -
Identification of New Genetic Markers for the Risk of Recurrence of Venous Thromboembolism by Whole Genome Analysis
|
||
Recruiting |
NCT06057844 -
Molecular Imaging of Active Venous Thrombus With Positron Emission Tomography (PET)
|
N/A | |
Completed |
NCT04243122 -
Assessing Feasibility of Thromboprophylaxis With Apixaban in JAK2-positive Myeloproliferative Neoplasm Patients
|
Phase 2 | |
Active, not recruiting |
NCT06443905 -
Xueshuantong Injection (Lyophilized) in the Prevention of Venous Thromboembolism (VTE) in Hospitalized Patients
|
||
Recruiting |
NCT02156401 -
VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE
|